HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Deppong, C. Articles by Green, J. M. Search for Related Content PubMed PubMed Citation Articles by Deppong, C. Articles by Green, J. M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Allergy Pneumonia

Cutting Edge: B and T Lymphocyte Attenuator and Programmed Death Receptor-1 Inhibitory Receptors Are Required for Termination of Acute Allergic Airway Inflammation¹

Christine Deppong^*,, Twyla I. Juehne^*, Michelle Hurchla^,, Lindzy D. Friend^*,, Dulari D. Shah^*, Christine M. Rose^*, Traci L. Bricker^*, Laurie P. Shornick^*, Erika C. Crouch, Theresa L. Murphy, Michael J. Holtzman^*,, Kenneth M. Murphy^,¶ and Jonathan M. Green^2,*,

^* Department of Internal Medicine, Program in Immunology, Department of Pathology and Immunology, Department of Cell Biology, and ^¶ Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110

T cell activation is regulated by coordinate interaction of the T cell Ag receptor and costimulatory signals. Although there is considerable insight into processes that regulate the initiation of inflammation, less is known about the signals that terminate immune responses. We have examined the role of the inhibitory receptors programmed death receptor-1 and B and T lymphocyte attenuator in the regulation of allergic airway inflammation. Our results demonstrate that there is a temporally regulated expression of both the receptors and their ligands during the course of allergic airway inflammation. Following a single inhaled challenge, sensitized wild-type mice exhibit peak inflammation on day 3, which resolves by day 10. In contrast, mice deficient in the expression of programmed death receptor-1 or B and T lymphocyte attenuator have persistent inflammation out to 15 days following challenge. Thus, these receptors are critical determinants of the duration of allergic airway inflammation.

This article has been cited by other articles:

				H. M'Hidi, M.-L. Thibult, B. Chetaille, F. Rey, R. Bouadallah, R. Nicollas, D. Olive, and L. Xerri High Expression of the Inhibitory Receptor BTLA in T-Follicular Helper Cells and in B-Cell Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia Am J Clin Pathol, October 1, 2009; 132(4): 589 - 596. [Abstract] [Full Text] [PDF]

				A. Crawford and E. J. Wherry Editorial: Therapeutic potential of targeting BTLA J. Leukoc. Biol., July 1, 2009; 86(1): 5 - 8. [Full Text] [PDF]

				W. Truong, W. W. Hancock, J. C. Plester, S. Merani, D. C. Rayner, G. Thangavelu, K. M. Murphy, C. C. Anderson, and A. M. J. Shapiro BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice J. Leukoc. Biol., July 1, 2009; 86(1): 41 - 51. [Abstract] [Full Text] [PDF]

				X. Liu, M. Alexiou, N. Martin-Orozco, Y. Chung, R. I. Nurieva, L. Ma, Q. Tian, G. Kollias, S. Lu, D. Graf, et al. Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance Induction J. Immunol., April 15, 2009; 182(8): 4516 - 4520. [Abstract] [Full Text] [PDF]

				C. Deppong, J. M. Degnan, T. L. Murphy, K. M. Murphy, and J. M. Green B and T Lymphocyte Attenuator Regulates T Cell Survival in the Lung J. Immunol., September 1, 2008; 181(5): 2973 - 2979. [Abstract] [Full Text] [PDF]

				M. W. Steinberg, O. Turovskaya, R. B. Shaikh, G. Kim, D. F. McCole, K. Pfeffer, K. M. Murphy, C. F. Ware, and M. Kronenberg A crucial role for HVEM and BTLA in preventing intestinal inflammation J. Exp. Med., June 9, 2008; 205(6): 1463 - 1476. [Abstract] [Full Text] [PDF]

				R. Tao, L. Wang, K. M. Murphy, C. C. Fraser, and W. W. Hancock Regulatory T Cell Expression of Herpesvirus Entry Mediator Suppresses the Function of B and T Lymphocyte Attenuator-Positive Effector T Cells J. Immunol., May 15, 2008; 180(10): 6649 - 6655. [Abstract] [Full Text] [PDF]

				C. A. Nelson, M. D. Fremont, J. R. Sedy, P. S. Norris, C. F. Ware, K. M. Murphy, and D. H. Fremont Structural Determinants of Herpesvirus Entry Mediator Recognition by Murine B and T Lymphocyte Attenuator J. Immunol., January 15, 2008; 180(2): 940 - 947. [Abstract] [Full Text] [PDF]

				K. Takamura, S. Fukuyama, T. Nagatake, D.-Y. Kim, A. Kawamura, H. Kawauchi, and H. Kiyono Regulatory Role of Lymphoid Chemokine CCL19 and CCL21 in the Control of Allergic Rhinitis J. Immunol., November 1, 2007; 179(9): 5897 - 5906. [Abstract] [Full Text] [PDF]

				B. Lepenies, K. Pfeffer, M. A. Hurchla, T. L. Murphy, K. M. Murphy, J. Oetzel, B. Fleischer, and T. Jacobs Ligation of B and T Lymphocyte Attenuator Prevents the Genesis of Experimental Cerebral Malaria J. Immunol., September 15, 2007; 179(6): 4093 - 4100. [Abstract] [Full Text] [PDF]

				M. A. Hurchla, J. R. Sedy, and K. M. Murphy Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation J. Immunol., May 15, 2007; 178(10): 6073 - 6082. [Abstract] [Full Text] [PDF]